Fluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Stomach or Gastroesophageal Junction

NCT01360086 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Adenocarcinoma of the Gastroesophageal Junction
Gastric Cancer

Interventions

BIOLOGICAL: cetuximab
DRUG: cisplatin
DRUG: fluorouracil
DRUG: leucovorin calcium
PROCEDURE: adjuvant therapy
PROCEDURE: neoadjuvant therapy
PROCEDURE: quality-of-life assessment
PROCEDURE: therapeutic conventional surgery

Sponsor

Federation Francophone de Cancerologie Digestive